156 related articles for article (PubMed ID: 20662097)
1. Characterization of ST2 transgenic mice with resistance to IL-33.
Ohto-Ozaki H; Kuroiwa K; Mato N; Matsuyama Y; Hayakawa M; Tamemoto H; Tominaga S
Eur J Immunol; 2010 Sep; 40(9):2632-42. PubMed ID: 20662097
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.
Shik D; Moshkovits I; Karo-Atar D; Reichman H; Munitz A
Allergy; 2014 Jun; 69(6):719-29. PubMed ID: 24735452
[TBL] [Abstract][Full Text] [Related]
3. ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance.
Liu J; Buckley JM; Redmond HP; Wang JH
J Immunol; 2010 May; 184(10):5802-8. PubMed ID: 20400705
[TBL] [Abstract][Full Text] [Related]
4. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.
Bulek K; Swaidani S; Qin J; Lu Y; Gulen MF; Herjan T; Min B; Kastelein RA; Aronica M; Kosz-Vnenchak M; Li X
J Immunol; 2009 Mar; 182(5):2601-9. PubMed ID: 19234154
[TBL] [Abstract][Full Text] [Related]
5. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
6. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
7. CXCR6
Obata-Ninomiya K; Ishiwata K; Nakano H; Endo Y; Ichikawa T; Onodera A; Hirahara K; Okamoto Y; Kanuka H; Nakayama T
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9849-E9858. PubMed ID: 30275296
[TBL] [Abstract][Full Text] [Related]
8. Leishmania major-parasitized macrophages augment Th2-type T cell activation.
Chakkalath HR; Titus RG
J Immunol; 1994 Nov; 153(10):4378-87. PubMed ID: 7963516
[TBL] [Abstract][Full Text] [Related]
9. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
11. The potential role of IL-33/ST2 signaling in fibrotic diseases.
Gao Q; Li Y; Li M
J Leukoc Biol; 2015 Jul; 98(1):15-22. PubMed ID: 25881899
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.
Hong K; Lee Y; Lee S; Hong S; Bae S; Hong J; Choi J; Jhun H; Kwak A; Kim E; Jo S; Kang T; Cho YS; Kim YG; Kim S
Immunol Res; 2013 May; 56(1):122-30. PubMed ID: 23435764
[TBL] [Abstract][Full Text] [Related]
13. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
14. IL-33 exacerbates eosinophil-mediated airway inflammation.
Stolarski B; Kurowska-Stolarska M; Kewin P; Xu D; Liew FY
J Immunol; 2010 Sep; 185(6):3472-80. PubMed ID: 20693421
[TBL] [Abstract][Full Text] [Related]
15. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis.
Matsuba-Kitamura S; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Taki Y; Muto T; Ikeda T; Mimura O; Nakanishi K
Int Immunol; 2010 Jun; 22(6):479-89. PubMed ID: 20501612
[TBL] [Abstract][Full Text] [Related]
16. IL-33/ST2 axis promotes mast cell survival via BCLXL.
Wang JX; Kaieda S; Ameri S; Fishgal N; Dwyer D; Dellinger A; Kepley CL; Gurish MF; Nigrovic PA
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10281-6. PubMed ID: 24982172
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury.
Yin H; Huang BJ; Yang H; Huang YF; Xiong P; Zheng F; Chen XP; Chen YF; Gong FL
Biochem Biophys Res Commun; 2006 Dec; 351(4):940-6. PubMed ID: 17097607
[TBL] [Abstract][Full Text] [Related]
19. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue.
Zeyda M; Wernly B; Demyanets S; Kaun C; Hämmerle M; Hantusch B; Schranz M; Neuhofer A; Itariu BK; Keck M; Prager G; Wojta J; Stulnig TM
Int J Obes (Lond); 2013 May; 37(5):658-65. PubMed ID: 22828942
[TBL] [Abstract][Full Text] [Related]
20. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation.
Chensue SW; Ruth JH; Warmington K; Lincoln P; Kunkel SL
J Immunol; 1995 Oct; 155(7):3546-51. PubMed ID: 7561051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]